A NASAL CLINICAL-GENOMIC CLASSIFIER FOR ASSESSING RISK OF MALIGNANCY IN LUNG NODULES DEMONSTRATES ACCURATE PERFORMANCE INDEPENDENT OF NODULE SIZE OR CANCER STAGE